ArticleResearch square2024

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.

Kavya Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.